Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Overview

Explore Rhythm Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

RYTM●NASDAQ
HealthcareBiotechnology
$95.71
$2.85(2.89%)
U.S. Market opens in 6h 26m

Rhythm Pharmaceuticals, Inc. (RYTM)

Meyka AI Score

Z

Key Financials

Market Cap6.6B
P/E Ratio-31.00
EPS (TTM)$-3.11
ROE-0.80%
Fundamental Analysis

AI Price Forecasts

1 Month$109.86
3 Months$110.38
1 Year Target$128.99

RYTM Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Rhythm Pharmaceuticals, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of RYTM on the NASDAQ shows an RSI of 33.60, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $128.99 for the NASDAQ listing.

Key metrics behind Rhythm Pharmaceuticals, Inc.'s NASDAQ-traded stock include a P/E ratio of -31.00 and a market capitalization of 6.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of RYTM on the NASDAQ.

Price Performance (NASDAQ: RYTM)

1-Day Change
-2.89%
5-Day Change
-2.07%
1-Month Change
-10.69%
3-Month Change
-13.02%
6-Month Change
26.23%
Year-to-Date (YTD) Change
-10.58%
1-Year Change
-4.90%
3-Year Change
317.49%
5-Year Change
625.63%
All-Time (Max) Change
219.03%

Contact Information

https://www.rhythmtx.com
857 264 4280
222 Berkeley Street, Boston, MA, 02116

Company Facts

4,140 Employees
IPO DateOct 9, 2017
CountryUS
Actively Trading

Frequently Asked Questions